IOVANCE BIOTHERAPEUTICS, INC.
IOVA
DELAYED 1 MONTH
23 insider filings · Latest: Jun 5, 2026
Common Stock Transactions
No transactions found.
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 5, 2026 | Jun 9 9:03 PM | Frederick G VogtDirector, Interim CEO & General Counsel | Option Exercise | 15,625 | — | 109,382(D) | View → |
| Jun 5, 2026 | Jun 9 9:01 PM | Finckenstein Friedrich GrafChief Medical Officer | Option Exercise | 7,813 | — | 54,691(D) | View → |
| Jun 5, 2026 | Jun 9 9:00 PM | Raj K. PuriChief Regulatory Officer | Option Exercise | 9,766 | — | 68,365(D) | View → |
| Jun 5, 2026 | Jun 9 9:00 PM | Igor BilinskyChief Operating Officer | Option Exercise | 7,813 | — | 54,691(D) | View → |
| Jun 1, 2026 | Jun 3 9:02 PM | Frederick G VogtDirector, Interim CEO & General Counsel | Option Exercise | 41,668 | — | 125,007(D) | View → |
| Jun 1, 2026 | Jun 3 9:01 PM | Raj K. PuriChief Regulatory Officer | Option Exercise | 5,469 | — | 16,409(D) | View → |
| Jun 1, 2026 | Jun 3 9:00 PM | Finckenstein Friedrich GrafChief Medical Officer | Option Exercise | 8,790 | — | 26,369(D) | View → |
| Jun 1, 2026 | Jun 3 9:00 PM | Igor BilinskyChief Operating Officer | Option Exercise | 8,790 | — | 26,369(D) | View → |
| May 11, 2026 | May 13 9:00 PM | Daniel Gordon KirbyChief Commercial Officer | Option Exercise | 10,000 | — | 70,004(D) | View → |
| Mar 9, 2026 | Mar 11 9:25 PM | Corleen M. RocheChief Financial Officer | Grant/Award | 132,200 | — | 132,200(D) | View → |
| Mar 9, 2026 | Mar 11 9:07 PM | Frederick G VogtDirector, Interim CEO & General Counsel | Grant/Award | 235,000 | — | 235,000(D) | View → |
| Mar 9, 2026 | Mar 11 9:04 PM | Raj K. PuriChief Regulatory Officer | Grant/Award | 117,500 | — | 117,500(D) | View → |
| Mar 9, 2026 | Mar 11 9:02 PM | Finckenstein Friedrich GrafChief Medical Officer | Grant/Award | 58,750 | — | 58,750(D) | View → |
| Mar 9, 2026 | Mar 11 9:01 PM | Daniel Gordon KirbyChief Commercial Officer | Grant/Award | 132,200 | — | 132,200(D) | View → |
| Mar 9, 2026 | Mar 11 9:00 PM | Igor BilinskyChief Operating Officer | Grant/Award | 117,500 | — | 117,500(D) | View → |
| Mar 5, 2026 | Mar 6 10:02 PM | Frederick G VogtDirector, Interim CEO & General Counsel | Option Exercise | 62,493 | — | 125,007(D) | View → |
| Mar 5, 2026 | Mar 6 10:01 PM | Finckenstein Friedrich GrafChief Medical Officer | Option Exercise | 31,246 | — | 62,504(D) | View → |
| Mar 5, 2026 | Mar 6 10:00 PM | Raj K. PuriChief Regulatory Officer | Option Exercise | 39,059 | — | 78,131(D) | View → |
| Mar 5, 2026 | Mar 6 10:00 PM | Igor BilinskyChief Operating Officer | Option Exercise | 31,246 | — | 62,504(D) | View → |
| Mar 2, 2026 | Mar 4 10:01 PM | Frederick G VogtDirector, Interim CEO & General Counsel | Option Exercise | 52,087 | — | 0(D) | View → |
Page 1 of 2
Next →